Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $45.25 -3.64%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Holcim to acquire Fermacell from James Hardie for EUR 840M
- CPS Technologies signs 80,000-sq-ft lease in Attleboro, Massachusetts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
